No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
EC Healthcare, an investment holding firm, delivers an extensive range of medical and healthcare services throughout Hong Kong, Macau, and mainland China. Its operations are structured into three primary divisions: Medical, Aesthetic Medical and Beauty and Wellness, and an 'Others' category. The company's diverse service offerings include quasi-medical treatments, beauty and wellness programs, medical imaging, surgical procedures, aesthetic medicine, dentistry, hair restoration, vaccinations, chiropractic care, psychological support, and orthopedic services. Beyond direct patient care, EC Healthcare also provides administrative and management support, laboratory diagnostics, various marketing and performance marketing solutions, and even travel agency services. Furthermore, it retails beauty and skincare products, manages healthcare machinery, engages in property investment, offers multi-channel networking, and extends its expertise to veterinary services. Its product and service portfolio is primarily marketed under proprietary brands such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. Established in 2005 and headquartered in Mong Kok, Hong Kong, the company was formerly known as Union Medical Healthcare Limited before rebranding to EC Healthcare in April 2021.
www.echealthcare.comNo one on the platform currently holds 2138.HK.
No tracked institution reports a position in 2138.HK as of their last filing.
No one on the platform has traded 2138.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -8.9% | 12.6% | ||||
| Profit Margin % | -10.7% | -1.3% | 7.9% | |||
| Free Cash Flow Margin % | 16.1% | 12.4% | 14.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $5.0B | +5.7% | $0.02 | $0.02–$0.02 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2138.HKEC Healthcare | $0.50 | -1.96% | $588M | — |
| 0157.HKNatural Beauty Bio-Technology Limited | $0.45 | +0.00% | $901M | — |
| 0399.HKStarcoin Group Limited | $0.07 | +32.73% | $165M | — |
| 0464.HKChina In-Tech Limited | $0.70 | -4.11% | $529M | — |
| 0809.HKGlobal Bio-chem Technology Group Company Limited | $0.37 | +0.00% | $606M | — |
| 0875.HKCongyu Intelligent Agricultural Holdings Limited | $0.29 | -1.69% | $203M | — |
| 1569.HKMinsheng Education Group Company Limited | $0.11 | +3.77% | $464M | — |
Source: Financial Modeling Prep · peers by sector/industry